| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |